Taysha Gene Therapies, Inc. (TSHA)

5.50 -0.16 (-2.83%) USD  |  NASDAQ  |  Dec 31, 16:00
5.74 +0.24 (+4.36%) Pre-Market: 08:52
More

Taysha Gene Therapies EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TSHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
AngioDynamics, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade
Bolt Biotherapeutics, Inc. Upgrade
Neurogene, Inc. Upgrade
Aspire Biopharma Holdings, Inc. --